Status:
COMPLETED
Cortisol in the Treatment of Phobias
Lead Sponsor:
University of Zurich
Collaborating Sponsors:
University Hospital, Basel, Switzerland
Conditions:
Phobia
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
The aim of this prospective, double-blind, placebo-controlled, randomized study is to investigate if glucocorticoid treatment, in combination with exposure therapy, helps to reduce phobic fear in pati...
Eligibility Criteria
Inclusion
- \- Female and male patients with a specific phobia (fear of heights) according to DSM-IV criteria.
Exclusion
- Severe acute or chronic somatic diseases
- Psychiatric disorder other than specific phobia
- Topic glucocorticoid therapy (for large skin parts)
- Inhaled glucocorticoids
- Psychotropic medication
- Pregnancy
Key Trial Info
Start Date :
May 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2009
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00451750
Start Date
May 1 2007
End Date
September 1 2009
Last Update
January 12 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Basel
Basel, Switzerland, 4055